![Letter to HCPs Letter to HCPs](/us-en/sites/novartis_us/files/styles/crop_freeform/public/2022-03/leter-to-hcps-final-2020-07-28-image_0.jpg.webp?itok=E10KfSB1)
Novartis enters into Corporate Integrity Agreement with Office of Inspector General (OIG) of the US Department of Health & Human Services
Novartis enters into Corporate Integrity Agreement with Office of Inspector General (OIG) of the US Department of Health & Human Services